Virpax Pharmaceuticals, Inc. (VRPX) has 7 open-market insider trades by 5 insiders since 2021. The most active filer is Anthony P. Mack, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Anthony P. Mack | CEO | — | 2 | $302K | 2022-05-18 |
| Gary S. Jacob | Dir | — | 1 | $24K | 2021-02-17 |
| Jerrold Sendrow | Dir | — | 2 | $21K | 2022-05-24 |
| Eric Floyd | Dir | — | 1 | $6K | 2022-05-18 |
| Thani Jambulingam | Dir | — | 1 | $716 | 2021-02-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jerrold Sendrow | Director | Buy | $6K | 2022-05-24 |
| Anthony P. Mack | CEO | Buy | $102K | 2022-05-18 |
| Eric Floyd | Director | Buy | $6K | 2022-05-18 |
| Jerrold Sendrow | Director | Buy | $15K | 2021-11-22 |
| Anthony P. Mack | CEO | Buy | $200K | 2021-11-18 |
| Gary S. Jacob | Director | Buy | $24K | 2021-02-17 |
Companies that share insiders with VRPX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Thani Jambulingam | Director | Buy | $716 | 2021-02-17 |